The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Molecular mechanisms involved in NAFLD progression
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Herschkovitz, A., Liu, Y., Ilan, E., Ronen, D., Boura‐Halfon, S., & Zick, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610949200 · Cited by 101
RetractedRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 8×
“The increased SOCS-1 and SOCS-3 cause a prominent upregulation of SREBP-1c [57], which in turn activates Acetyl-CoA carboxylase-2 (ACC2) [58], an isoform of ACC that produces malonyl-CoA at the mitochondrial membrane [59] (Fig.”
BackgroundInfluentialInsulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard, J., Maachi, M., Lagathu, C., Kim, M. J., Caron, M., Vidal, H., Capeau, J., & Fève, B. (2006) · PubMed · Cited by 2,496
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
Ryter, S. W., Alam, J., & Choi, A. M. K. (2006) · Physiological Reviews · doi:10.1152/physrev.00011.2005 · Cited by 2,307
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · cited 1×
“The mice expressing constitutively IKK-β in hepatocytes exhibit a type 2 diabetes phenotype, hepatic IR, and increased production of TNF-α [42–44].”
BackgroundNonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
IKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications
Maines, M. D. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.10.3290025 · Cited by 1,707
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Horton, J. D., Shah, N. A., Warrington, J. A., Anderson, N. N., Park, S. W., Brown, M. S., & Goldstein, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1534923100 · Cited by 1,270
Chitturi, S., Abeygunasekera, S., Farrell, G. C., Holmes-Walker, J., Hui, J. M., Fung, C., Karim, R., Lin, R., Samarasinghe, D., Liddle, C., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.30692 · Cited by 1,122
Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,015
Schulze-Osthoff, K., Bakker, A. C., Vanhaesebroeck, B., Beyaert, R., Jacob, W. A., & Fiers, W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42768-8 · Cited by 939
Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P. A., Moser, A. B., DeSimone, C., Song, X.-Y., & Diehl, A. M. (2003) · Hepatology · doi:10.1053/jhep.2003.50048 · Cited by 930
IRS proteins and the common path to diabetes
White, M. F. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00514.2001 · Cited by 925
Nonalcoholic Steatohepatitis: Definition and Pathology
Brunt, E. M. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12925 · Cited by 911
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2
Abu-Elheiga, L., Matzuk, M. M., Abo-Hashema, K. A. H., & Wakil, S. J. (2001) · Science · doi:10.1126/science.1056843 · Cited by 903
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Role of Kupffer cells in host defense and liver disease
Bilzer, M., Roggel, F., & Gerbes, A. L. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01342.x · Cited by 856
Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
Virkamäki, A., Ueki, K., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6609 · Cited by 854 · cited 2×
“The liver is not only an end organ for the effects of IR, but it is also an important regulator of carbohydrate homeostasis, which is under the control of insulin signaling, acting through binding to its specific receptor [23].”
BackgroundIizuka, K., Bruick, R. K., Liang, G., Horton, J. D., & Uyeda, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401516101 · Cited by 785
Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase Complex
Gao, Z., Hwang, D., Bataille, F., Lefevre, M., York, D., Quon, M. J., & Ye, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209459200 · Cited by 778
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
Leclercq, I. A., Farrell, G. C., Field, J., Bell, D. R., Gonzalez, F. J., & Robertson, G. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8814 · Cited by 764
The epidemiology of nonalcoholic fatty liver disease in adults.
Clark, J. M. (2006) · PubMed · doi:10.1097/01.mcg.0000168638.84840.ff · Cited by 762
Mitochondrial dysfunction in Nash: causes, consequences and possible means to prevent it
Begriche, K., Igoudjil, A., Pessayre, D., & Fromenty, B. (2006) · Mitochondrion · doi:10.1016/j.mito.2005.10.004 · Cited by 753 · cited 1×
“Mitochondria are the first organelle to be impaired, as suggested by decreased mitochondrial fatty acid oxidation and increased compensatory peroxisomal fatty acid oxidation [17].”
BackgroundShimomura, I., Bashmakov, Y., & Horton, J. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30028 · Cited by 708
Gavrilova, O., Haluzik, M., Matsusue, K., Cutson, J. J., Johnson, L., Dietz, K. R., Nicol, C. J., Vinson, C., Gonzalez, F. J., & Reitman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300043200 · Cited by 707
Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways
Schwabe, R. F., & Brenner, D. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00422.2005 · Cited by 685
A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver
Yamashita, H., Takenoshita, M., Sakurai, M., Bruick, R. K., Henzel, W. J., Shillinglaw, W., Arnot, D., & Uyeda, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161284298 · Cited by 682
ADD1/SREBP1 activates PPARγ through the production of endogenous ligand
Kim, J. B., Wright, H. M., Wright, M., & Spiegelman, B. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4333 · Cited by 669
Ratziu, V., Giral, P., Jacqueminet, S., Charlotte, F., Hartemann–Heurtier, A., Serfaty, L., Podevin, P., Lacorte, J., Bernhardt, C., Bruckert, E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.078 · Cited by 625
Matsumoto, M., Pocai, A., Rossetti, L., DePinho, R. A., & Accili, D. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.006 · Cited by 615
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Weltman, M. D., Farrell, G. C., Hall, P., Ingelman-Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 614
Vuppalanchi, R., & Chalasani, N. (2009) · Hepatology · doi:10.1002/hep.22603 · Cited by 563
Frescas, D., Valenti, L., & Accili, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412357200 · Cited by 533
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease
Kohjima, M., Enjoji, M., Higuchi, N., Kato, M., Kotoh, K., Yoshimoto, T., Fujino, T., Yada, M., Yada, R., Harada, N., et al. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.3.351 · Cited by 529
Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients
VIDELA, L. A., RODRIGO, R., ORELLANA, M., FERNANDEZ, V., TAPIA, G., QUIÑONES, L., VARELA, N., CONTRERAS, J., LAZARTE, R., CSENDES, A., et al. (2004) · Clinical Science · doi:10.1042/cs20030285 · Cited by 515
Samuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497
The subcellular localization of acetyl-CoA carboxylase 2
Abu-Elheiga, L., Brinkley, W. R., Zhong, L., Chirala, S. S., Woldegiorgis, G., & Wakil, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1444 · Cited by 453
Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases
Loguercio, C., Federico, A., Tuccillo, C., Terracciano, F., D'Auria, M. V., De Simone, C., & Blanco, C. D. V. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000165671.25272.0f · Cited by 449
Lu, S. C., Alvarez, L., Huang, Z.-Z., Chen, L., An, W., Corrales, F. J., Avila, M. A., Kanel, G., & Mato, J. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091016398 · Cited by 449
Fajas, L., Schoonjans, K., Gelman, L., Kim, J. B., Najib, J., Martin, G., Fruchart, J.-C., Briggs, M., Spiegelman, B. M., & Auwerx, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5495 · Cited by 444
Obesity Induces Expression of Uncoupling Protein-2 in Hepatocytes and Promotes Liver ATP Depletion
Chavin, K. D., Yang, S., Lin, H. Z., Chatham, J., Chacko, V. P., Hoek, J. B., Walajtys-Rode, E., Rashid, A., Chen, C.-H., Huang, C.-C., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5692 · Cited by 441
Bugianesi, E., Manzini, P., D'Antico, S., Vanni, E., Longo, F., Leone, N., Massarenti, P., Piga, A., Marchesini, G., & Rizzetto, M. (2004) · Hepatology · doi:10.1002/hep.20023 · Cited by 440
c-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade
Lee, Y. H., Giraud, J., Davis, R. J., & White, M. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208359200 · Cited by 438
Mechanism for Fatty Acid “Sparing” Effect on Glucose-induced Transcription
Kawaguchi, T., Osatomi, K., Yamashita, H., Kabashima, T., & Uyeda, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107895200 · Cited by 423
Kim, Y. D., Park, K.-G., Lee, Y.-S., Park, Y.-Y., Kim, D.-K., Nedumaran, B., Jang, W. G., Cho, W.-J., Ha, J., Lee, I.-K., et al. (2008) · Diabetes · doi:10.2337/db07-0381 · Cited by 422
Nguyen, M. T. A., Satoh, H., Favelyukis, S., Babendure, J. L., Imamura, T., Sbodio, J. I., Zalevsky, J., Dahiyat, B. I., Chi, N.-W., & Olefsky, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504611200 · Cited by 411 · cited 3×
“In NAFLD patients, primary defect in insulin receptors causes the downregulation of IRS-1 signaling by excess FFAs [37], which activate the stress/ inflammatory kinases JNK, IKK-β, and suppressors of cytokine signaling-3 (SOCS-3) contributing to IR [38, 39] (Fig.”
BackgroundSakurai, T., Maeda, S., Chang, L., & Karin, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603499103 · Cited by 400
Day, C. P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.017 · Cited by 395
Raabe, M., Véniant, M. M., Sullivan, M. A., Zlot, C. H., Björkegren, J., Nielsen, L. B., Wong, J. S., Hamilton, R. L., & Young, S. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6576 · Cited by 395
Ribeiro, P. S., Cortez-Pinto, H., Solá, S., Castro, R. E., Ramalho, R. M., Baptista, A., Moura, M. C., Camilo, M. E., & Rodrigues, C. M. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40009.x · Cited by 395
Mitochondria in Steatohepatitis
Pessayre, D., Berson, A., Fromenty, B., & Mansouri, A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12929 · Cited by 391
Abu-Elheiga, L., Oh, W., Kordari, P., & Wakil, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1733877100 · Cited by 389
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
Schattenberg, J. M., Singh, R., Wang, Y., Lefkowitch, J. H., Rigoli, R. M., Scherer, P. E., & Czaja, M. J. (2006) · Hepatology · doi:10.1002/hep.20999 · Cited by 384 · cited 15×
“The insulin binding to its receptor activates the phosphorylation of insulin receptor substrates IRS-1 and IRS-2, which are the main mediators of insulin signaling in the liver [25] (Fig.”
BackgroundInfluentialPPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes
Schadinger, S. E., Bucher, N. L. R., Schreiber, B. M., & Farmer, S. R. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00513.2004 · Cited by 376
II. Cytochrome P-450 enzymes and oxidative stress
Robertson, G., Leclercq, I., & Farrell, G. C. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.5.g1135 · Cited by 358
Defects of the insulin receptor substrate (IRS) system in human metabolic disorders
Sesti, G., Federici, M., Hribal, M. L., Lauro, D., Sbraccia, P., & Lauro, R. (2001) · The FASEB Journal · doi:10.1096/fj.01-0009rev · Cited by 353
Mecanismos de lesión hepatocelular
Muntané, J., González, R., Ranchal, I., Collado, J. A., López-Sánchez, L. M., Herencia, C., Rodríguez-Ariza, A., Muñoz-Castañeda, J. R., & de la Mata, M. (2007) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082007000700007 · Cited by 349
Fan, C.-Y., Pan, J., Usuda, N., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15639 · Cited by 343 · cited 1×
“Moreover, it has been observed that mice lacking the gene encoding fatty acyl-CoA oxidase (AOX), the initial enzyme of the peroxisomal β-oxidation system, develop severe microvesicular NASH [107].”
BackgroundApolipoprotein synthesis in nonalcoholic steatohepatitis
Charlton, M., Sreekumar, R., Rasmussen, D., Lindor, K., & Nair, S. K. (2002) · Hepatology · doi:10.1053/jhep.2002.32527 · Cited by 333
Svegliati-Baroni, G., Ridolfi, F., Di Sario, A., Casini, A., Marucci, L., Gaggiotti, G., Orlandoni, P., Macarri, G., Perego, L., Benedetti, A., et al. (1999) · Hepatology · doi:10.1002/hep.510290632 · Cited by 320
Boot, R. G., van Achterberg, T. A. E., van Aken, B. E., Renkema, G. H., Jacobs, M. J. H. M., Aerts, J. M. F. G., & de Vries, C. J. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.687 · Cited by 317
Alcoholic steatosis and steatohepatitis.
Maher, J. J. (2002) · PubMed · Cited by 315
Pathophysiology of Nonalcoholic Steatohepatitis
Başaranoğlu, M. (2009) · Cited by 293
Xu, Z., Chen, L., Leung, L., Yen, T. S. B., Lee, C., & Chan, J. Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500660102 · Cited by 292
Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition
Cave, M., Deaciuc, I., Mendez, C., Song, Z., Joshi-Barve, S., Barve, S., & McClain, C. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.12.006 · Cited by 291
Duce, A. M., Ortíz, P., Cabrero, C., & Mato, J. M. (1988) · Hepatology · doi:10.1002/hep.1840080113 · Cited by 286
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.013 · Cited by 272 · cited 1×
“Statins (atorvastatin, pravastatin, and rosuvastatin) decrease serum transaminases [145] and serum lipid levels by inhibiting HMG-CoA reductase and induce a significant reduction in hepatic steatosis [146].”
BackgroundLeonarduzzi, G., Scavazza, A., Biasi, F., Chiarpotto, E., Camandola, S., Vogl, S., Dargel, R., & Poli, G. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.11.9285483 · Cited by 264
Gao, Z., Zuberi, A., Quon, M. J., Dong, Z., & Ye, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300423200 · Cited by 258
Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes
Han, M. S., Park, S. Y., Shinzawa, K., Kim, S., Chung, K. W., Lee, J.-H., Kwon, C. H., Lee, K.-W., Lee, J.-H., Park, C. K., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700184-jlr200 · Cited by 257
A Model of Insulin Resistance and Nonalcoholic Steatohepatitis in Rats
Svegliati-Baroni, G., Candelaresi, C., Saccomanno, S., Ferretti, G., Bachetti, T., Marzioni, M., De Minicis, S., Nobili, L., Salzano, R., Omenetti, A., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050953 · Cited by 256
Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction
Adams, L. A., Feldstein, A., Lindor, K. D., & Angulo, P. (2004) · Hepatology · doi:10.1002/hep.20140 · Cited by 252
Bedossa, P., Houglum, K., Trautwein, C., Holstege, A., & Chojkier, M. (1994) · Hepatology · doi:10.1002/hep.1840190527 · Cited by 249
Chitturi, S., Weltman, M., Farrell, G. C., McDonald, D., Liddle, C., Samarasinghe, D., Lin, R., Abeygunasekera, S., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33892 · Cited by 247
The role of GSK3 in glucose homeostasis and the development of insulin resistance
Lee, J., & Kim, M.-S. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.033 · Cited by 245
Prada, P. O., Zecchin, H. G., Gasparetti, A. L., Torsoni, M. A., Ueno, M., Hirata, A. E., Corezola do Amaral, M. E., Höer, N. F., Boschero, A. C., & Saad, M. J. A. (2005) · Endocrinology · doi:10.1210/en.2004-0767 · Cited by 244
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†
Lutchman, G., Modi, A., Kleiner, D. E., Promrat, K., Heller, T., Ghany, M., Borg, B., Loomba, R., Liang, T. J., Premkumar, A., et al. (2007) · Hepatology · doi:10.1002/hep.21661 · Cited by 244
Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD)
Song, J., Da Costa, K. A., Fischer, L. M., Kohlmeier, M., Kwock, L., Wang, S., & Zeisel, S. H. (2005) · The FASEB Journal · doi:10.1096/fj.04-3580com · Cited by 239
Namikawa, C., Shu-Ping, Z., Vyselaar, J. R., Nozaki, Y., Nemoto, Y., Ono, M., Akisawa, N., Saibara, T., Hiroi, M., Enzan, H., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.01.028 · Cited by 234
Martinez, S. C., Tanabe, K., Cras-Méneur, C., Abumrad, N. A., Bernal-Mizrachi, E., & Permutt, M. A. (2008) · Diabetes · doi:10.2337/db07-0595 · Cited by 223
Gao, J., & Serrero, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16825 · Cited by 214
Mitochondrial Glutathione: Importance and Transport
Fernández-Checa, J., Kaplowitz, N., García-Ruiz, C., & Colell, A. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007172 · Cited by 211
Polymorphisms in the Methylenetetrahydrofolate Reductase Gene: Clinical Consequences
Schwahn, B., & Rozen, R. (2001) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200101030-00004 · Cited by 199
Probiotic and Prebiotic Influence Beyond the Intestinal Tract
Lenoir-Wijnkoop, I., Sanders, M. E., Cabana, M. D., Caglar, E., Corthier, G., Rayes, N., Sherman, P. M., Timmerman, H. M., Vaneechoutte, M., Loo, J. V., et al. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00272.x · Cited by 198
Targeting farnesoid X receptor for liver and metabolic disorders
Fiorucci, S., Rizzo, G., Donini, A., Distrutti, E., & Santucci, L. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.06.001 · Cited by 196
Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-δ
Lam, T. K. T., Yoshii, H., Haber, C. A., Bogdanovic, E., Lam, L., Fantus, I. G., & Giacca, A. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00038.2002 · Cited by 195
Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling
Schattenberg, J. M., Wang, Y., Singh, R., Rigoli, R. M., & Czaja, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410310200 · Cited by 194 · cited 3×
“Increased CYP2E1 expression in hepatocytes and the presence of steatohepatitis result in the downregulation of insulin signaling, contributing, in part, to the IR [40].”
BackgroundCellular Sources of Collagen and Regulation of Collagen Production in Liver
Friedman, S. (1990) · Seminars in Liver Disease · doi:10.1055/s-2008-1040454 · Cited by 194
Peroxisomal β-Oxidation and Steatohepatitis
Rao, M. S., & Reddy, J. K. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12928 · Cited by 193
PPARα Agonists Inhibit Tissue Factor Expression in Human Monocytes and Macrophages
Neve, B. P., Corseaux, D., Chinetti, G., Zawadzki, C., Fruchart, J.-C., Duriez, P., Staels, B., & Jude, B. (2001) · Circulation · doi:10.1161/01.cir.103.2.207 · Cited by 191
Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis
Valenti, L., Rametta, R., Dongiovanni, P., Maggioni, M., Ludovica Fracanzani, A., Zappa, M., Lattuada, E., Roviaro, G., & Fargion, S. (2008) · Diabetes · doi:10.2337/db07-0714 · Cited by 187
Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet
Motomura, W., Inoue, M., Ohtake, T., Takahashi, N., Nagamine, M., Tanno, S., Kohgo, Y., & Okumura, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.121 · Cited by 178
Samuel, V. T., Choi, C. S., Phillips, T. G., Romanelli, A. J., Geisler, J. G., Bhanot, S., McKay, R., Monia, B., Shutter, J. R., Lindberg, R. A., et al. (2006) · Diabetes · doi:10.2337/db05-0705 · Cited by 177
Malaguarnera, L., Madeddu, R., Palio, E., Arena, N., & Malaguarnera, M. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.040 · Cited by 173
Self-citationEvidence That IRS-2 Phosphorylation Is Required for Insulin Action in Hepatocytes
Rother, K. I., Imai, Y., Caruso, M., Beguinot, F., Formisano, P., & Accili, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17491 · Cited by 167
Lessons from animal models of NASH
Diehl, A. M. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.022 · Cited by 162
Imai, Y., Varela, G. M., Jackson, M. B., Graham, M. J., Crooke, R. M., & Ahima, R. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.046 · Cited by 161
Nakae, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25518 · Cited by 146
Kumar, N., & Dey, C. S. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704878 · Cited by 145
Tarantino, G., Conca, P., Basile, V., Gentile, A., Capone, D., Polichetti, G., & Leo, E. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00072.x · Cited by 145
PPARγ agonists prevent TGFβ1/Smad3-signaling in human hepatic stellate cells
Zhao, C., Chen, W., Yang, L., Chen, L., Stimpson, S. A., & Diehl, A. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.069 · Cited by 139
Chitotriosidase: the yin and yang
Malaguarnera, L. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6269-2 · Cited by 134
Self-citationThe heme oxygenase-carbon monoxide system: u regulator of hepatobiliary function
Suematsu, M., & Ishimura, Y. (2000) · Hepatology · doi:10.1002/hep.510310102 · Cited by 132
Mitochondrial glutathione: Hepatocellular survival–death switch
García‐Ruiz, C., & Fernández-Checa, J. C. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04570.x · Cited by 131
Role of SNAP23 in Insulin-induced Translocation of GLUT4 in 3T3-L1 Adipocytes
Kawanishi, M., Tamori, Y., Okazawa, H., Araki, S., Shinoda, H., & Kasuga, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.8240 · Cited by 129
Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis
Başkol, G., Başkol, M., & Koçer, D. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.02.006 · Cited by 128
The Role of Cytokines and Chemokines in the Development of Steatohepatitis
Lalor, P. F., Faint, J., Aarbodem, Y., Hübscher, S. G., & Adams, D. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-979470 · Cited by 128
Liver fibrosis: a balance of ACEs?
Warner, F. J., Lubel, J. S., McCaughan, G. W., & Angus, P. (2007) · Clinical Science · doi:10.1042/cs20070026 · Cited by 124
Dong, H., Wang, J., Li, C., Hirose, A., Nozaki, Y., Takahashi, M., Ono, M., Akisawa, N., Iwasaki, S., Saibara, T., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.12.012 · Cited by 120
Loguercio, C., Federico, A., Trappoliere, M., Tuccillo, C., de Sio, I., Di Leva, A., Niosi, M., D’Auria, M. V., Capasso, R., Blanco, C. D. V., et al. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9703-2 · Cited by 116
Malaguarnera, L., Rosa, M. D., Zambito, A. M., dell’Ombra, N., Nicoletti, F., & Malaguarnera, M. (2006) · Gut · doi:10.1136/gut.2005.075697 · Cited by 112
Self-citationSustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice
Choi, S. S., Sicklick, J. K., Ma, Q., Yang, L., Huang, J., Qi, Y. P., Chen, W., Li, Y.-X., Goldschmidt‐Clermont, P. J., & Diehl, A. M. (2006) · Hepatology · doi:10.1002/hep.21375 · Cited by 108
Duseja, A. K., Das, A., Dhiman, R. K., Chawla, Y. K., Thumburu, K. K., Bhadada, S. K., & Bhansali, A. K. (2007) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31902-7 · Cited by 103
Lappas, M., Yee, K., Permezel, M., & Rice, G. E. (2004) · Endocrinology · doi:10.1210/en.2004-0809 · Cited by 102
Ueki, K., KADOWAKI, T., & Kahn, C. R. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.032 · Cited by 101
Ghanim, H., Aljada, A., Daoud, N., Deopurkar, R., Chaudhuri, A., & Dandona, P. (2007) · Diabetologia · doi:10.1007/s00125-006-0508-9 · Cited by 96
Mordier, S., & Iynedjian, P. B. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.004 · Cited by 96
Duong, D. T., Waltner-Law, M. E., Sears, R., Sealy, L., & Granner, D. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204873200 · Cited by 94
George, J., & Liddle, C. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700110z · Cited by 91
Interaction of liver methionine adenosyltransferase with hydroxyl radical
Sánchez-Góngora, E., Ruiz, F. A., Mingorance, J., et al. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.12.9337154 · Cited by 90
Song, Z., Zhou, Z., Uriarte, S. M., Wang, L., Kang, Y. J., Chen, T., Barve, S. S., & McClain, C. J. (2004) · Hepatology · doi:10.1002/hep.20412 · Cited by 90
The Heme Oxygenase System: Its Role in Liver Inflammation
Wunder, C., & Potter, R. F. (2003) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1568006033481410 · Cited by 89
Yakaryılmaz, F., Güliter, S., Savaş, B., Erdem, Ö., Ersoy, R., Erden, E., Akyol, G., Bozkaya, H., & Özenirler, S. (2007) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01295.x · Cited by 88
Foxo1 links insulin signaling to C/EBPα and regulates gluconeogenesis during liver development
Sekine, K., Chern, E., Kojima, N., Ogata, K., Fukamizu, A., & Miyajima, A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601784 · Cited by 88
Balas, B., Belfort, R., Harrison, S. A., Darland, C., Finch, J., Schenker, S., Gastaldelli, A., & Cusi, K. J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.013 · Cited by 88
Potential Role of Chitotriosidase Gene in Nonalcoholic Fatty Liver Disease Evolution
Malaguarnera, L., Rosa, M. D., Zambito, A. M., dell'Ombra, N., Marco, R. D., & Malaguarnera, M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00680.x · Cited by 85
Self-citationTirmenstein, M. A., Nicholls-Grzemski, F. A., Zhang, G., & Fariss, M. W. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00180-0 · Cited by 83
Glutathione‐enhancing agents protect against steatohepatitis in a dietary model
Oz, H. S., Im, H., Chen, T. S., de Villiers, W. J. S., & McClain, C. J. (2006) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20109 · Cited by 79
Hui, Y., Li, Y., Yu‐Qiang, N., Wei‐Hong, S., Du, Y., Xiao-bo, L., & Yong-jian, Z. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01623.x · Cited by 77
Liu, H.-Y., Collins, Q. F., Xiong, Y., Moukdar, F., Lupo, E. G., Liu, Z., & Cao, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609701200 · Cited by 75
Rosa, M. D., Musumeci, M., Scuto, A., Musumeci, S., & Malaguarnera, L. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.088 · Cited by 75
Self-citationSerum Lipids, Lipoproteins and Apolipoproteins Levels in Patients With Nonalcoholic Steatohepatitis
Koruk, M., Savaş, M., Yilmaz, Ö., Tayşi, S., Karakök, M., Gündoğdu, C., & Yilmaz, A. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200308000-00017 · Cited by 72
Fujita, K., Yoneda, M., Wada, K., Mawatari, H., Takahashi, H., Kirikoshi, H., Inamori, M., Nozaki, Y., Maeyama, S., Saito, S., et al. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9741-4 · Cited by 68
Varki, A. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4523 · Cited by 68
Regulation of microsomal triglyceride transfer protein mRNA expression by endotoxin and cytokines
Navasa, M., Gordon, D. A., Hariharan, N., Jamil, H., Shigenaga, J. K., Moser, A. H., Fiers, W., Pollock, A. S., Grünfeld, C., & Feingold, K. R. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32546-3 · Cited by 68
Lalli, C. A., Pauli, J. R., Prada, P. O., Cintra, D. E., Ropelle, E. R., Velloso, L. A., & Saad, M. J. A. (2007) · Metabolism · doi:10.1016/j.metabol.2007.07.021 · Cited by 67
N‐Acetylcysteine in The Treatment Of Non‐Alcoholic Steatohepatitis
Pamuk, G. E., & Sonsuz, A. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03156.x · Cited by 64
Sario, A. D., Bendia, E., Taffetani, S., Omenetti, A., Candelaresi, C., Marzioni, M., Deminicis, S., & Benedetti, A. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2005.05.011 · Cited by 57
Malaguarnera, L., Pilastro, M. R., Quan, S., Ghattas, M. H., Yang, L. M., Mezentsev, A., Kushida, T., Abraham, N. G., & Kappas, A. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.10.4.433 · Cited by 54
Self-citationWu, D., & Cederbaum, A. I. (2007) · Hepatology · doi:10.1002/hep.22087 · Cited by 54
Malaguarnera, L., Imbesi, R., Rosa, M. D., Scuto, A., Castrogiovanni, P., Messina, A., & Sanfilippo, S. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.04.002 · Cited by 53
Self-citationPKCδ-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function
Greene, M. W., Ruhoff, M. S., Roth, R. A., Kim, J., Quon, M. J., & Krause, J. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.158 · Cited by 48
Temporal and spatial assembly of lipid droplet-associated proteins in 3T3-L1 preadipocytes
Hwang, R., Wang, S., Yeo, H.-L., & Greenberg, A. S. (2003) · Histochemistry and Cell Biology · doi:10.1007/s00418-003-0575-7 · Cited by 48
Current Pharmacological Treatment of Nonalcoholic Fatty Liver
Publisher, B. S. P. B. S. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706778521878 · Cited by 46
Le Foll, C., Corporeau, C., Le Guen, V., Gouygou, J.-P., Bergé, J.-P., & Delarue, J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00446.2006 · Cited by 45
Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH)
AGARWAL, N., & Sharma, B. C. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.09.012 · Cited by 44
Nakano, S., Inada, Y., Masuzaki, H., Tanaka, T., Yasue, S., Ishii, T., Arai, N., Ebihara, K., Hosoda, K., Maruyama, K., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00340.2006 · Cited by 44
Mouse glycosylphosphatidylinositol-specific phospholipase D ( Gpld1 ) characterization
LeBoeuf, R. C., Caldwell, M., Guo, Y., Metz, C. N., Davitz, M. A., Olson, L. K., & Deeg, M. A. (1998) · Mammalian Genome · doi:10.1007/s003359900851 · Cited by 40
Salicylate Blocks Lipolytic Actions of Tumor Necrosis Factor-α in Primary Rat Adipocytes
Zu, L., Jiang, H., He, J., Xu, C. B., Pu, S., Liu, M., & Xu, G. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039479 · Cited by 40
Medical Treatment of Non-alcoholic Steatohepatitis
Kadayıfçı, A., Merriman, R. B., & Bass, N. M. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.001 · Cited by 40
Bianchi, G., Brizi, M., Rossi, B., Ronchi, M., Grossi, G., & Marchesini, G. (2000) · Metabolism · doi:10.1053/meta.2000.16554 · Cited by 38
The impact of pregnane X receptor activation on liver fibrosis
Wright, M. C. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341119 · Cited by 38
Chalasani, N., Vuppalanchi, R., Raikwar, N. S., & Deeg, M. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0075 · Cited by 36
Caldwell, S. H., Patrie, J. T., Brunt, E. M., Redick, J. A., Davis, C. A., Park, S. H., & Neuschwander‐Tetri, B. A. (2007) · Hepatology · doi:10.1002/hep.21813 · Cited by 34
Parola, M., & Novo, E. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.008 · Cited by 23
Habara, K., Hamada, Y., Yamada, M., Tokuhara, K., Tanaka, H., Kaibori, M., Kamiyama, Y., Nishizawa, M., Ito, S., & Okumura, T. (2007) · Nitric Oxide · doi:10.1016/j.niox.2007.08.005 · Cited by 21
NASH: Can we iron out the pathogenesis?
Blendis, L. M., Oren, R., & Halpern, Z. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70189-2 · Cited by 15
Jiménez‐López, J. M., & Cederbaum, A. I. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076737 · Cited by 9
[Role of PPARs in the pathophysiology of nonalcoholoic fatty liver disease].
Tanaka, T., Masuzaki, H., & Nakao, K. (2005) · PubMed · Cited by 8
Cited by
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Del Chierico, F., Nobili, V., Vernocchi, P., Russo, A., De Stefanis, C., Gnani, D., Furlanello, C., Zandonà, A., Paci, P., Capuani, G., et al. (2017) · Hepatology · doi:10.1002/hep.28572 · Cited by 696
“Thus, quantitative and qualitative variations in the bacteria that compose the gut microbiota may actively contribute to the pathogenesis of several liver diseases, including nonalcoholic fatty liver disease (NAFLD), alcoholic steatohepatitis, and cirrhosis.((2-7)) NAFLD is one of the most common causes of chronic liv…”
BackgroundMethodResultInfluentialAlternative macrophage activation and metabolism
Odegaard, J. I., & Chawla, A. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130138 · Cited by 640
Toll-Like Receptor 4 Is Involved in the Development of Fructose-Induced Hepatic Steatosis in Mice†
Spruss, A., Kanuri, G., Wagnerberger, S., Haub, S., Bischoff, S. C., & Bergheim, I. (2009) · Hepatology · doi:10.1002/hep.23122 · Cited by 562
Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
Malaguarnera, M., Vacante, M., Antic, T., Giordano, M., Chisari, G., Acquaviva, R., Mastrojeni, S., Malaguarnera, G., Mistretta, A., Li Volti, G., et al. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1887-4 · Cited by 455
Self-citation
Metadata
- Authors
- Malaguarnera, M., Di Rosa, M., Nicoletti, F., & Malaguarnera, L.
- Venue
- Journal of Molecular Medicine
- Published
- 2009-04-08
- Volume
- 87
- Issue
- 7
- Pages
- 679-695
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W2126904532
- Cited by
- 282
- References
- 169
- FWCI
- 13.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.